Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4537 - 4544 of 11613 results
New Developments with HRAs
August 27, 2019| Video| Viewpoint
HHS Drug Pricing Disclosure Rule: Chance at a Renewed Life Following District Court Appeal?
August 26, 2019| Blog| Viewpoint
Recent Decision Holds That Litigation Funding Does Not Harm Standing and Provides Tips for Negotiating Funding Agreements
August 26, 2019| Blog| Viewpoint
Facsimiles and Other Fossils: FTC Initiates Review to Update COPPA Rule to Keep Pace with Emerging and Connected Technology
August 26, 2019| Blog| Viewpoint
Impact of Cyan, Inc. v. Beaver County Decision
August 23, 2019| Video| Viewpoint
Alexa: What is venue?
August 23, 2019| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.